Sorafenib-Induced Spiny Follicular Hyperkeratosis: A Case Report with Review of Literature

Sorafenib is a multikinase inhibitor used in the treatment of various solid tumors. Mucocutaneous adverse events are experienced by 70 to 90% of the patients receiving sorafenib, underscoring the importance of awareness among oncologists and dermatologists. Spiny follicular hyperkeratosis (SFH) is a...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Indian journal of medical and paediatric oncology 2024-04, Vol.45 (2), p.183-187
Hauptverfasser:	Shajil, Chandana, Sathishkumar, Dharshini, Boddu, Deepthi, Telugu, Ramesh Babu
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!